Oncology Research Today is a free monthly online journal that collates and summarizes the latest research about Oncology, including details on cancer, surgery, chemotherapy, radiotherapy.

Volume 4 (2008), Issue 4 (April)

1. Efficacy and safety of a mixture of ketamine, midazolam and atropine for procedural sedation in paediatric oncology: a randomised study of oral versus intramuscular route.
   J Paediatr Child Health, 44(4): 201-4. [Abstract] [Full-text]
2. Oral chemotherapy in paediatric oncology in the UK: problems, perceptions and information needs of parents.
   Pharm World Sci. [Abstract] [Full-text]
3. Gefitinib plus celecoxib in chemotherapy-naïve patients with stage IIIB/IV non-small cell lung cancer: a phase II study from the Hoosier Oncology Group.
   J Thorac Oncol, 3(4): 374-9. [Abstract] [Full-text]
4. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
   J Thorac Oncol, 3(4): 365-73. [Abstract] [Full-text]
5. Integration of a palliative and terminal care center into a comprehensive pediatric oncology department.
   Pediatr Blood Cancer, 50(5): 949-55. [Abstract] [Full-text]
6. Adolescent and young adult oncology: transition of care.
   Pediatr Blood Cancer, 50(5): 1116-9. [Abstract] [Full-text]
7. Imaging in the era of molecular oncology.
   Nature, 452(7187): 580-9. [Abstract] [Full-text]
8. Management of Frail and Not-Frail elderly cancer patients in a hospital-based geriatric oncology program.
   Crit Rev Oncol Hematol, 66(2): 163-70. [Abstract] [Full-text]
9. Living with cancer and perception of care: Icelandic oncology outpatients, a qualitative study.
   Support Care Cancer, 16(5): 515-24. [Abstract] [Full-text]
10. Treatment of B-cell lymphoma with LMB modified protocols in Africa--report of the French-African Pediatric Oncology Group (GFAOP).
    Pediatr Blood Cancer, 50(6): 1138-42. [Abstract] [Full-text]
11. Integrative oncology: complementary therapies for cancer survivors.
    Hematol Oncol Clin North Am, 22(2): 343-53. [Abstract] [Full-text]
12. Determining perceived learning needs of newly employed pediatric oncology registered nurses.
    J Nurses Staff Dev, 24(2): 69-74. [Abstract] [Full-text]
13. Erythropoietin-stimulating agents in oncology.
    Cancer J, 14(2): 75-84. [Abstract] [Full-text]
14. Factors affecting the evolution of oncology nursing care.
    Clin J Oncol Nurs, 12(2): 307-13. [Abstract] [Full-text]
15. The AIM Higher Initiative: New Procedures Implemented for Assessment, Information, and Management of Chemotherapy Toxicities in Community Oncology Clinics.
    Clin J Oncol Nurs, 12(2): 229-38. [Abstract] [Full-text]
16. Does regular follow-up influence the survival of patients with sarcoma after recurrence? The Miri Shitrit pediatric oncology department experience.
    J Pediatr Hematol Oncol, 30(3): 189-95. [Abstract] [Full-text]
17. Oncology employees valued patient-oriented research over quality of work-life research: a qualitative study.
    J Clin Epidemiol, 61(5): 471-4. [Abstract] [Full-text]
18. Recent developments in urologic oncology: positron emission tomography molecular imaging.
    Curr Opin Oncol, 20(3): 321-6. [Abstract] [Full-text]
19. Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438).
    Blood, 111(8): 4048-54. [Abstract] [Full-text]
20. Improvement in oncology practice performance through voluntary participation in the Quality Oncology Practice Initiative.
    J Clin Oncol, 26(11): 1893-8. [Abstract] [Full-text]
21. Pain, Distress, and Adult-Child Interaction during Venipuncture in Pediatric Oncology: An Examination of Three Types of Venous Access.
    J Pain Symptom Manage. [Abstract] [Full-text]
22. Quantifying pediatric neuro-oncology risk factors: development of the neurological predictor scale.
    J Child Neurol, 23(4): 455-8. [Abstract] [Full-text]
23. Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118.
    Int J Radiat Oncol Biol Phys, 71(1): 71-8. [Abstract] [Full-text]
24. Antifungal susceptibility against yeasts isolated from pediatric oncology patients.
    Med Mycol, 46(4): 337-43. [Abstract] [Full-text]
25. Dimensions of informal care in Greece: the family's contribution to the care of patients hospitalized in an oncology hospital.
    J Clin Nurs, 17(10): 1287-94. [Abstract] [Full-text]
26. Phase II study of docetaxel in combination with oxaliplatin in patients with metastatic or locally advanced esophagogastric cancer previously untreated with chemotherapy for advanced disease: results of the Central European Cooperative Oncology Group Study ESGAS.1.2.001.
    Anticancer Drugs, 19(5): 535-9. [Abstract] [Full-text]
27. Serum protein expression profiling in pediatric Hodgkin lymphoma: A report from the Children's Oncology Group.
    Pediatr Blood Cancer. [Abstract] [Full-text]
28. Peer-supported storytelling for grieving pediatric oncology nurses.
    J Pediatr Oncol Nurs, 25(3): 148-63. [Abstract] [Full-text]
29. Mistletoe therapy in oncology.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
30. Symptoms and signs of port-related infections in oncology patients related to the offending pathogens.
    Int J Clin Pract. [Abstract] [Full-text]
31. Quality of Training in Radiation Oncology in Germany : Results of a 2006 Survey.
    Strahlenther Onkol, 184(5): 239-244. [Abstract] [Full-text]
32. Vitamin supplement use among children with Down's syndrome and risk of leukaemia: a Children's Oncology Group (COG) study.
    Paediatr Perinat Epidemiol, 22(3): 288-95. [Abstract] [Full-text]
33. The principle of respect for autonomy - concordant with the experience of oncology physicians and molecular biologists in their daily work?
    BMC Med Ethics, 9: 5. [Abstract] [Full-text]
34. A SAS-based solution to evaluate study design efficiency of phase I pediatric oncology trials via discrete event simulation.
    Comput Methods Programs Biomed, 90(3): 240-50. [Abstract] [Full-text]
35. A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    Blood, 111(9): 4496-9. [Abstract] [Full-text]
36. Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group Study.
    Cancer, 112(9): 1954-63. [Abstract] [Full-text]
37. Polymer-drug conjugates: recent development in clinical oncology.
    Adv Drug Deliv Rev, 60(8): 886-98. [Abstract] [Full-text]
38. Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00.
    Ann Oncol, 19(5): 853-60. [Abstract] [Full-text]
39. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
    Crit Rev Oncol Hematol, 66(3): 237-47. [Abstract] [Full-text]
40. A randomized phase II study of ixabepilone (BMS-247550) given daily x 5 days every 3 weeks or weekly in patients with metastatic or recurrent squamous cell cancer of the head and neck: an Eastern Cooperative Oncology Group study.
    Ann Oncol, 19(5): 977-83. [Abstract] [Full-text]
41. Prognostic versus predictive value of biomarkers in oncology.
    Eur J Cancer, 44(7): 946-53. [Abstract] [Full-text]
42. The challenge of conducting pharmacoeconomic evaluations in oncology using crossover trials: The example of sunitinib for gastrointestinal stromal tumour.
    Eur J Cancer, 44(7): 972-7. [Abstract] [Full-text]
43. Development of Communities of Practice to Facilitate Quality Improvement Initiatives in Surgical Oncology.
    Qual Manag Health Care, 17(2): 174-185. [Abstract] [Full-text]
44. A medical student-staffed outpatient oncology clinic: a 10-year brazilian experience.
    J Cancer Educ, 23(1): 63-4. [Abstract] [Full-text]
45. Teaching complementary medicine at an academic oncology department.
    J Cancer Educ, 23(1): 46-50. [Abstract] [Full-text]
46. Effect of white cell counts on the presence of human herpes simplex virus type-1 in saliva of pediatric oncology patients.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 105(5): 583-8. [Abstract] [Full-text]
47. Sexual issues in special populations: geriatric oncology - sexuality and older adults.
    Semin Oncol Nurs, 24(2): 120-6. [Abstract] [Full-text]
48. Oncology hematology. Incorporating geriatric oncology. Follicular lymphomas.
    Crit Rev Oncol Hematol, 66(3): 248-61. [Abstract] [Full-text]
49. Oncology hematology. Incorporating geriatric oncology. Oligodendroglioma.
    Crit Rev Oncol Hematol, 66(3): 262-72. [Abstract] [Full-text]
50. Use of thromboprophylaxis in palliative care patients: a survey among experts in palliative care, oncology, intensive care, and anticoagulation.
    Am J Hosp Palliat Care, 25(2): 127-31. [Abstract] [Full-text]
51. Consistency of phase III clinical trial abstracts presented at an annual meeting of the American Society of Clinical Oncology compared with their subsequent full-text publications.
    J Clin Oncol, 26(13): 2205-11. [Abstract] [Full-text]
52. Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study.
    J Clin Oncol, 26(13): 2186-91. [Abstract] [Full-text]

© 2005-2008 Oncology Research Today. All Rights Reserved.